Use of cerebrospinal fluid CXCL10 and neopterin as biomarkers in HTLV-1-associated myelopathy/tropical spastic paraparesis treated with steroids

J Neurol Neurosurg Psychiatry. 2020 Mar;91(3):321-323. doi: 10.1136/jnnp-2019-321955. Epub 2019 Oct 29.

¹ Department of Rare Diseases Research, Institute of Medical Science, St. Marianna University School of Medicine, Kawasaki, Japan.
² Department of Advanced Medical Innovation, St. Marianna University Graduate School of Medicine, Kawasaki, Japan.
³ Department of Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, Michigan, USA.
⁴ Medical Informatics, St. Marianna University School of Medicine, Kanagawa, Japan.
⁵ Department of Preventive Medicine, St. Marianna University School of Medicine, Kawasaki, Japan.
⁶ Department of Neurology, St. Marianna University School of Medicine, Kawasaki, Japan.
⁷ Department of Rare Diseases Research, Institute of Medical Science, St. Marianna University School of Medicine, Kawasaki, Japan yyamano@marianna-u.ac.jp.

No abstract available

Keywords: HTLV1.

Publication types